Tory Speert, DO
Interventional Pain Medicine · Saratoga Springs, NYNPI 1972843548
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 244 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by Nevro Corp. at 31.6% of the total. Reporting peaked in 2019 at $2,668 and has fallen 62.8% since, to $991 in 2025.
Across 244 payments — averaging $46.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$4K
- Boston Scientific$3K
- Vertos Medical, Inc.$1K
- Abbott$1K
- Saluda Medical Americas, Inc.$640
- Ferring Pharmaceuticals Inc.$413
- plus $907 from 18 others
What the payments were for
- Food & beverage$11,342100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 66 | $3,579 |
| Boston Scientific | 48 | $3,402 |
| Vertos Medical, Inc. | 27 | $1,272 |
| Abbott | 27 | $1,128 |
| Saluda Medical Americas, Inc. | 7 | $640 |
| Ferring Pharmaceuticals Inc. | 35 | $413 |
| Prodigy Surgical Distribution, Inc. | 1 | $200 |
| Johnson & Johnson | 4 | $105 |
| Globus Medical | 4 | $96 |
| Pacira Therapeutics, Inc. | 3 | $77 |
| Relievant Medsystems, Inc. | 2 | $75 |
| Amgen | 3 | $50 |
| Bioventus LLC | 2 | $42 |
| Arbor Pharmaceuticals, Inc. | 3 | $40 |
| Organogenesis Inc. | 1 | $40 |
| AbbVie | 3 | $38 |
| Foundation Fusion Solutions, LLC | 1 | $28 |
| Vertex | 1 | $23 |
| Kowa Pharmaceuticals America, Inc. | 1 | $23 |
| Scilex Pharmaceuticals Inc. | 1 | $22 |
| IBSA Pharma Inc. | 1 | $21 |
| Pfizer | 1 | $14 |
| Medtronic | 1 | $13 |
| SPR Therapeutics, Inc | 1 | $1 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,342 in reported general payments places this provider in the 75th percentile of 132 interventional pain medicine providers in New York.
See all interventional pain medicine providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 316 | $10,961 |
| Gabapentin | 676 | $9,391 |
| Pregabalin | 160 | $7,964 |
| Celecoxib | 98 | $3,558 |
| Lidocaine | 17 | $1,053 |
| Diclofenac Sodium | 58 | $600 |
| Baclofen | 29 | $599 |
| Meloxicam | 160 | $581 |
| Tizanidine Hcl | 31 | $573 |
| Methocarbamol | 69 | $563 |
| Cyclobenzaprine Hcl | 60 | $409 |
| Tramadol Hcl | 21 | $170 |
| Topiramate | 12 | $98 |
| Alprazolam | 38 | $91 |
| Prednisone | 23 | $59 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Saratoga Springs
- Corey HunterNew York$446K
- Neel MehtaNew York$432K
- Hemant KaliaRochester$179K
- Martin FerrilloAlbany$164K
- George ChaseKew Gardens$102K
- Kimberly SackheimNew York$102K
- Suelane OuroNew York$68K
- Gerard DegregorisNew York$49K
- Jafar SiddiquiWilliamsville$45K
- Alexander WeingartenSyosset$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.